Efficacy of Pre-Hospital Use of Glycoprotein IIb/IIIa Inhibitors in ST-Segment Elevation Myocardial Infarction Before Mechanical Reperfusion in a Rapid-Transfer.

Slides:

Advertisements

Similar presentations

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Advertisements

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions Pranav Puri, Jennifer Carroll,

Severity of Coronary Arterial Stenoses Responsible for Acute Coronary Syndromes Ganesh Manoharan, MD, Argyrios Ntalianis, MD, Olivier Muller, MD, PhD,

Relation of Heart Rate at Rest and Long-Term (>20 Years) Death Rate in Initially Healthy Middle-Aged Men Xavier Jouven, MD, PhD, Jean Philippe Empana,

Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction.

PP-183 [AJC » Percutaneous coronary interventions in acute coronary syndromes] Succesful Treatment and Management of LMCA Acute Total Occlusion in a Patient.

The Epidemic of the 20th Century: Coronary Heart Disease

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention Mehmet.

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.

Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and.

Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Frequency of Percutaneous Coronary Interventions at Facilities Without On-Site Cardiac Surgical Backup—A Report from the American College of Cardiology–National.

Community-Based Mind–Body Meditative Tai Chi Program and Its Effects on Improvement of Blood Pressure, Weight, Renal Function, Serum Lipoprotein, and.

Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies David Nanchen, MD, Arnaud Chiolero, MD,

Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.

Meta-Analysis of Dietary Glycemic Load and Glycemic Index in Relation to Risk of Coronary Heart Disease Jia-Yi Dong, BSc, Yong-Hong Zhang, MD, PhD, Peiyu.

Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial) Mohsen Sharifi, MD, Curt Bay, PhD, Laura Skrocki, DO, Farnoosh Rahimi,

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction.

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Laszlo Littmann, MD, PhD The American Journal of Medicine

Discharge Heart Rate and Mortality after Acute Myocardial Infarction

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Short-Term Prognosis of Myocardial Injury, Type 1, and Type 2 Myocardial Infarction in the Emergency Unit Alain Putot, MD, MSc, Sophie Buet Derrida,

Wandering Acute Myocardial Infarction

Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes Avi Sabbag, MD, Shlomi Matetzky,

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

The Epidemic of the 20th Century: Coronary Heart Disease

Laszlo Littmann, MD, PhD The American Journal of Medicine

Kay Lee Park, MD, Robert J. Goldberg, PhD, Frederick A

Quality of Care for Myocardial Infarction at Academic and Nonacademic Hospitals Loic Belle, MD, José Labarère, MD, Magali Fourny, MSc, Elodie Drouet,

The DRESS Syndrome: A Literature Review

Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndromes: Troponin Alone Is not Enough Philippe Gabriel Steg, Gordon FitzGerald, Keith.

Why surgery won the SYNTAX trial and why it matters

When Guidelines Cause Hypertension

Figure 4 Observational studies on multiple treatment strategies

John P. Vavalle, MD, MHS, Renato D. Lopes, MD, PhD, Anita Y

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Peripartum Cardiomyopathy Presenting as an Acute Myocardial Infarction

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care Marc Cohen, MD Mayo Clinic Proceedings

For everything there is a season

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Effect of Spironolactone on Physical Performance in Older People with Self-reported Physical Disability Louise A. Burton, MD, Deepa Sumukadas, MD, Miles.

Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Laszlo Littmann, MD, PhD, Michael H. Monroe, MD

Tombstone ST Elevations: … Not Necessarily a Harbinger of Doom!

From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.

Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex Naji Kholaif,

Has mortality from acute renal failure decreased

Figure 2 The spatial distribution of plaque erosion and plaque rupture in the coronary arteries. Bar graph (A): the ... Figure 2 The spatial distribution.

Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome Zach Rozenbaum, MD, Avi Leader, MD, Yoram Neuman,

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Presentation transcript:

Efficacy of Pre-Hospital Use of Glycoprotein IIb/IIIa Inhibitors in ST-Segment Elevation Myocardial Infarction Before Mechanical Reperfusion in a Rapid-Transfer Network (from the Acute Myocardial Infarction Registry of Brittany) Vincent Auffret, MD, Emmanuel Oger, MD PhD, Guillaume Leurent, MD, Emmanuelle Filippi, MD, Isabelle Coudert, MD, Jean Philippe Hacot, MD, Philippe Castellant, MD, Antoine Rialan, MD, Régis Delaunay, MD, Gilles Rouault, MD, Philippe Druelles, MD, Bertrand Boulanger, MD, Josiane Treuil, MD, Bertrand Avez, MD, Marc Bedossa, MD, Dominique Boulmier, MD, Marielle Le Guellec, MSc, Hervé Le Breton, MD, PhD American Journal of Cardiology Volume 114, Issue 2, Pages 214-223 (July 2014) DOI: 10.1016/j.amjcard.2014.04.029 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Flowchart of the study. ORBI = Observatoire Regional Breton sur l’Infarctus; PCI = percutaneous coronary intervention. American Journal of Cardiology 2014 114, 214-223DOI: (10.1016/j.amjcard.2014.04.029) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Proportions of TIMI flow grades according to treatment groups. American Journal of Cardiology 2014 114, 214-223DOI: (10.1016/j.amjcard.2014.04.029) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Multivariate analysis. SBP = systolic blood pressure. American Journal of Cardiology 2014 114, 214-223DOI: (10.1016/j.amjcard.2014.04.029) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Rates of in-hospital MACEs and death according to treatment groups. American Journal of Cardiology 2014 114, 214-223DOI: (10.1016/j.amjcard.2014.04.029) Copyright © 2014 Elsevier Inc. Terms and Conditions